Ultragenyx Pharmaceutical: Wells Fargo raises target price to $19 from $18
RARE•Wells Fargo raised its target price for Ultragenyx Pharmaceutical to $19 from $18.
Related News
Truist Securities raises Expeditors target price to $200 from $175
EXPD•
GlobalFoundries management commentary: US government share issuance contributes to Q3 2026 pretax loss
GFS•
Lifecore Biomedical Q3 revenue misses estimates as CDMO, HA sales decline
LFCR•
Street view: How Pfizer makes up for patent expiries is key
PFE•
Shoals Technologies agrees to merge with ARRAY Technologies
SHLS•